BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26746331)

  • 1. A Modern Radiotherapy Series of Survival in Hispanic Patients with Glioblastoma.
    Wu CC; Wang TJC; Jani A; Estrada JP; Ung T; Chow DS; Soun JE; Saad S; Qureshi YH; Gartrell R; Saadatmand HJ; Saraf A; Garrett MD; Grubb CS; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; McKhann GM
    World Neurosurg; 2016 Apr; 88():260-269. PubMed ID: 26746331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
    Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
    Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.
    Chang EL; Yi W; Allen PK; Levin VA; Sawaya RE; Maor MH
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):519-28. PubMed ID: 12738329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report.
    Pashaki AS; Hamed EA; Mohamadian K; Abassi M; Safaei AM; Torkaman T
    Asian Pac J Cancer Prev; 2014; 15(6):2793-6. PubMed ID: 24761902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
    Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
    Pan IW; Ferguson SD; Lam S
    J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between race and survival in glioblastoma patients in the US: A retrospective cohort study.
    Bohn A; Braley A; Rodriguez de la Vega P; Zevallos JC; Barengo NC
    PLoS One; 2018; 13(6):e0198581. PubMed ID: 29927955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation response and survival time in patients with glioblastoma multiforme.
    Barker FG; Prados MD; Chang SM; Gutin PH; Lamborn KR; Larson DA; Malec MK; McDermott MW; Sneed PK; Wara WM; Wilson CB
    J Neurosurg; 1996 Mar; 84(3):442-8. PubMed ID: 8609556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
    Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme.
    Lai R; Hershman DL; Doan T; Neugut AI
    Neuro Oncol; 2010 Feb; 12(2):190-8. PubMed ID: 20150386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
    J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.